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Objectives: To determine the effect of preoperative renal failure on the outcome of patients uffering from infrarenaI 
abdominal aortic aneurysm (AAA). 
Method: During the period from January 1979 to August 1995, 364 patients with AAA were admitted to our hospital 
and 323 underwent elective reapir. The patients were retrospectively analysed in three groups. Group I was composed of 
273 patients with a normal renal function who underwent an aneurysm repair. Group II was composed of 50 patients 
who demonstrated a preoperative renal dysfunction (creatinine above 2.0 mg/dl or creatinine clearance below 40 ml/min) 
and underwent an operation, including three patients maintained on chronic haemodialysis. Group III was composed of 
18 patients with a renal dysfunction who did not undergo repair, including one patient maintained on chronic 
haemodialysis. 
Results: The operative mortality rate of groups i and II were 0.4% and 2.0%, respectively, although no significant 
difference was observed. The incidence of postoperative cardiac and pulmonary complications were also comparable in 
two groups. No patients required acute haemodialysis. The 5-year survival rate of grou p II (44%) was significantly higher 
than that of group III (20%), and seven of the 18 patients (39%) in group III ultimately died of a rupture of the AAA. 
Conclusions: Patients with chronic renal failure can undergo an abdominal aortic aneurysm repair based on the same 
indications as those without renal failure. 
Introduction 
Elective repair of abdominal aortic aneurysm (AAA) 
can be safely carried out with an operative mortality 
about  3%. 1'2 Repair is advocated even in high risk 
patients, including those with severe coronary artery 
disease 3'4 and those who are 80 years of age and 
olderd '6 However, all surgeons recognise that some 
patients with AAA, because of multiple other medical 
problems, may be at an increased risk for aneurysm 
repair. Coronary artery disease is a major cause of 
morbidity and the major cause of mortality after the 
elective surgical repair of abdominal aortic aneurysm. 4'7 
However, little information is available on the outcome 
of such patients with renal failure. The purpose of this 
retrospective study was to determine the effect of 
preoperative r nal failure on the outcome of patients 
with AAA. 
* Address for correspondence: K. Komori. 
Materials and Methods 
From January 1979 through to August 1995, 364 
patients with abdominal aortic aneurysm were ad- 
mitted to our hospital. A total of 323 consecutive 
patients underwent elective repair of infrarenal ab- 
dominal aortic aneurysms and were classified into 
three groups: 273 patients had no renal dysfunction 
(group I), while 50 of the patients had preoperative 
renal dysfunction (creatinine above 2.0 mg/dl  or cre- 
atinine clearance below 40 ml/min) (group II). Group 
II included three patients maintained on chronic 
haemodialysis. Group III was composed of 18 patients 
with a renal dysfunction who did not undergo repair, 
including one patient maintained on chronic haemo- 
dialysis. The intra- and postoperative parameters be- 
tween the groups were compared. 
The routine evaluation for all patients with ab- 
dominal aortic aneurysm in our department was as 
follows: full blood count, chemistry, coagulation 
profile, creatinine clearance, arterial blood analysis, 
spirogram, chest roentgenogram, electrocardiogram, 
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Table 1. Demographics and risk factors of patients with abdominal aortic aneurysm. 
Group I Group II Group III 
Number 273 50 18 
Creatinine (mg/dl) 1.0 ±0.2 2.9 ±0.4* 2.2 ±0.4f 
Creatinine clearance (ml/min) 78.6 + 2.0 29.3 ± 1.6" 25.6 ± 2.5t 
Male 227 44 14 
Female 46 6 4 
Mean age (years) 68.6 ± 8.3 70.0 ± 7.4 72.6 + 7.7 
CT size (cm) 5.5 ± 1.6 5.6 ± 1.9 6.0 ±_ 1.6 
Cardiac disease 32.1% 46.0%* 56.2%f 
Hypertension 65.1% 82.0%* 77.8%f 
Pulmonary disease 49.0% 51.0% 66.7% 
Cerebrovascular disease 8.6% 20.0%* 17.6t 
Diabetes mellitus 7.8% 8.0% 16.7% 
Smoking 84.1% 95.5%* 83.3% 
Group I: patients with normal renal function who underwent AAA repair. 
Group II: patients with a renal dysfunction who underwent repair (creatinine above 2.0rag/ 
dl, or creatinine clearance below 40 ml/min), including three patients maintained on chronic 
haemodialysis. 
Group IIh patients with renal dysfunction who did not undergo repair. 
Significant difference between groups I and II. 
tSignificant difference between groups I and III. 
abdominal ultrasound scan, computed tomography 
and arteriography. Dipyridamole-thal l ium scinti- 
graphy was also performed, regardless of the history of 
angina or myocardial  infarction, fol lowed by coronary 
arteriography if indicated by scintigraphy. 
In the operating room the patient received at least 
two intravenous lines and an indwell ing urinary cath- 
eter. Central venous pressure was measured by sub- 
clavian vein puncture. An arterial ine was placed for 
blood pressure. A Swan-Ganz catheter was also used 
for the serial measurements of cardiac output and 
pulmonary capillary wedge pressure, which are mon- 
itored in patients with cardiac dysfunction. In the 
event of cardiac dysfunction, coronary vasodilators 
such as calcium-blocker or nitrovasodilators were ad- 
ministrated uring the operation and continued until 
at least the third postoperative day. If the patient had 
renal dysfunction, prostaglandin E1 was given during 
the operation and continued until the fifth post- 
operative day. 
Statistics 
The results are expressed as mean_s.]~.M. The stat- 
istical evaluation of the data was performed using 
Student's t-test for paired or unpaired observations. 
When more than two means were compared, an ana- 
lysis of variance was used. If the value was statistically 
significant, Scheffe's test for multiple comparisons was 
used to identify differences among the groups. A 
value of p<0.05 was considered to indicate statistical 
significance. 
Results 
In Table 1 the details of the patient demographics and 
the preoperative risk factors are given. There was 
a significant difference of creatinine and creatinine 
clearance between the groups I and II and between 
the groups I and III. There was no significant difference 
regarding the age of the patients or the size of the 
aneurysm between the three groups. The incidence of 
accompanying complications uch as hypertension, 
cardiac disease and cerebrovascular disease in groups 
II and III was higher than that of group I. 
Table 2. Intraoperative parameters. 
Group I Group II 
Operative time (min) 250 ± 77 239 i 89 
Clamping time (min) 55.8 ± 8.0 59.8 ± 3.1 
Intraoperative blood loss (ml) 1509 +1413 1338 ± 1123 
Table 3. Postoperative parameters. 
Group I Group II 
Initiation alimentation (days) 4.6 + 0.5 4.5 + 0.3 
Postoperative hospital±sat±on (days) 18.0 + 1.6 18.4 ± 0.4 
Postoperative mortality rate (%) 0.4 2.0 
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]Fig. 1. Survival curves demonstrating theinfluence ofrenal failure 
on long-term survival in the patients with abdominal ortic an- 
eurysm. The survival rate of group 1 was significantly higher than 
that of group II. The survival rate of group II was significantly 
higher khan that of group III. 
The intraoperative parameters evaluated are il- 
lustrated in Table 2. No significant difference was 
observed regarding the operation time, aortic clamping 
time and blood loss between groups I and II. The 
complications observed in group I were: fifteen 
patients (5.5%) with pulmonary complications and 
seven patients with cardiac omplications (2.6%). The 
complications seen in group II were: five patients (10%) 
with pulmonary complications and four patients with 
cardiac complications (8%). No significant difference 
was observed in the incidence of complications be- 
tween the two groups. 
The postoperative parameters evaluated are de- 
scribed in Table 3. No significant difference was seen 
regarding the initiation of alimentation and the length 
of postoperative hospitalisation between groups I and 
II. The postoperative mortality rates in groups I and 
II were 0.4% and 2.0%, respectively (not significant). 
After operation, no patients required haemodialysis 
during hospitalisation, except for three patients main- 
tained on chronic haemodialysis. 
Figure i shows the survival rate of the patients with 
AAA. The 1-, 3- and 5-year survival rates were 96.2%, 
88.0%, 78.1% in group I, and 75.7%, 57.9%, 43.5% in 
group II, respectively. The survival rate of group I was 
significantly higher than that of group II. The 1-, 3- 
and 5-year survival rates in group III were 40.0%, 
30.0%, 20.0%, respectively. The survival rate of group 
II was significantly higher than that of group III. The 
main cause of late death in group III was a rupture of 
the AAA. Seven of the 18 patients (39%) who did not 
undergo a resection of the AAA ultimately died due 
to rupture. 
Discussion 
Low mortality rates for the elective surgical treatment 
of abdominal aortic aneurysm justify an aggressive 
approach in most patients. 11-~3 Repair is now advocated 
even in high risk patients, including those with severe 
coronary artery disease 3'4 and those who are 80 years 
of age and older, 5'6 and patients with concomitant AAA 
and gastrointestinal malignancy. 8 However, in high 
risk patients with small aneurysms and no symptoms, 
the decision to operate still has to be made after 
carefully weighing the potential risk and benefits. 
Contraindications to elective resection have been 
well summarised, 9-11 and include recent acute myo- 
cardial infarction (within 3 months), intractable angina 
pectoris, severe pulmonary insufficiency (dyspnoea t 
rest), chronic renal insufficiency (BUN greater than 80, 
creatinine greater than 3), or other associated isease 
with a life expectancy of less than 2 years. 
The most striking finding of the present study was 
that in renal failure group, the 5-year survival rate of 
the patients who underwent repair was higher than 
those who did not. However, in the patients with renal 
failure who underwent repair, the 5-year survival rate 
was significantly ower than that of the patients with- 
out renal failure. It has been shown by many authors 
that coronary artery disease is a major cause of mor- 
bidity and the major cause of mortality after an elective 
surgical repair of AAA. 3'* Our results demonstrate that 
renal failure also affects the 5-year survival rate after 
AAA repair. 
Cohen et aI. TM recommended that patients with severe 
renal dysfunction (serum creatinine greater than 4mg/ 
dl) who are not on haemodialysis should be considered 
for dialysis preoperatively in an attempt to reduce the 
high incidence of serious postoperative r nal func- 
tional deterioration. In the present study no patients, 
including those with severe renal failure (serum cre- 
atinine greater than 4 mg/dl), required acute haemo- 
dialysis during hospitalisation. Cohen et al. reported 
that four of the six patients with severe renal dys- 
function developed significant postoperative de- 
terioration of renal function which required acute 
haemodialysis. Niva et al. reported an improvement 
of the renal function with prostaglandin E1 infusion 
in patients with chronic renal failure. ~5 The protective 
mechanism of PGE1 on postischaemic renal failure is 
not only a consequence of vasodilatation, but may also 
be due to a cytoprotective effect. L6 In order to protect 
the renal function during operation, prostaglandin E1
was given intravenously (10-20ng kg min) and was 
continued until the fifth postoperative day. The in- 
fusion of PGE1 may lead to renal protection. 
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In our department, the main indication to operate on 
patients with asymptomatic aneurysms is a diameter of 
4 cm, or twice the diameter of the normal inffarenal 
aorta. ~ Our results have demonstrated that there was 
no significant difference between the groups in either 
the intra- or postoperative parameters, including the 
operative time, the intraoperative blood loss, the initi- 
ation of oral intake and the duration of postoperative 
hospitalisation. In addition, no significant difference 
was observed in either the operative mortality rate or 
the incidence of postoperative complications. 
Eight of twenty-four patients who did not undergo 
repair ultimately died of an AAA rupture. Therefore, 
aggressive repair of abdominal aortic aneurysms in 
patients with renal dysfunction may result in a better 
survival rate, as the mortality rate for ruptured AAA 
is still h ighs  
We conclude that patients with chronic renal dys- 
function can undergo abdominal aortic aneurysm re- 
pair based on the same indications as those without 
renal failure. A more aggressive surgical approach is 
recommended for the treatment of AAA in patients 
with preoperative renal failure. 
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